TrendPulse Logo

RFK Jr. to face questioning in House, Senate

Source: The HillView Original
politicsApril 16, 2026

Health Care Newsletter

RFK Jr. to face questioning in House, Senate

by Joseph Choi and Nathaniel Weixel - 04/15/26 6:12 PM ET

Link copied

by Joseph Choi and Nathaniel Weixel - 04/15/26 6:12 PM ET

Link copied

96

- Presented by the Coalition to Strengthen America’s Healthcare

{beacon}

View Online

Health Care

Health Care

PRESENTED BY

The Big Story

Kennedy set for Hill visits

Health Secretary Robert F. Kennedy Jr. kicks off a whirlwind of congressional hearings on Thursday, testifying before the House Ways and Means Committee in the morning and the House Appropriations health subcommittee in the afternoon.

© Greg Nash

He will appear before an Education and Workforce subcommittee Friday. Next week, Kennedy is set to testify in a Senate Appropriations subcommittee, the Senate HELP Committee and the Senate Finance Committee.

Thursday will mark Kennedy’s first appearance on Capitol Hill since a highly contentious Senate Finance Committee hearing last September, where Democrats and even some Republicans grilled him about his vaccine views and leadership shakeups at the Centers for Disease Control and Prevention.

Kennedy’s hearings are about the HHS budget and he’ll likely face sharp questions from Democrats about the administration’s priorities: the White House proposal would cut HHS funding by 12.5 percent relative to what Congress approved for the current fiscal year, including deep reductions to the National Institutes of Health and the creation of a new Administration for a Healthy America (AHA).

The White House proposed a similar budget last year, but Congress ultimately allotted the agency $33 billion more than what the administration requested, with no funding for the AHA.

Kennedy’s written testimony provided in advance of his afternoon hearing will highlight the administration’s wins that are part of the Make America Healthy Again movement, including revamped dietary guidelines, working with companies to eliminate artificial food dyes, and an ongoing review of baby formula.

Kennedy will also talk about the administration’s drug pricing efforts and urge Congress to codify Trump’s Most Favored Nation deals.

Notably absent is any formal reference to vaccines, as the White House tries to navigate a political tightrope ahead of the midterm elections. Kennedy and his vaccine-skeptical allies have upended federal vaccine policy and made sweeping changes to the childhood vaccine schedule this year, moves that could be a liability for Republicans in November.

 

Welcome to The Hill’s Health Care newsletter, we’re Nathaniel Weixel and Joseph Choi — every week we follow the latest moves on how Washington impacts your health.

 

Did someone forward you this newsletter? Subscribe here.

 

Essential Reads

How policy will be impacting the health care sector this week and beyond:

 

Maryland separates from RFK Jr. vaccine guidance

Legislation signed by Maryland Gov. Wes Moore (D) would de-couple the state from following the recommendations of a federal vaccine advisory panel that was remade by Health Secretary Robert F. Kennedy Jr. The Vax Act, signed by Gov. Wes Moore (D) Tuesday, directs the state’s health secretary to issue official recommendations for immunizations, screening and preventive …

Full Story

 

Protect Our Care publishes scathing report of Kennedy’s tenure ahead of congressional hearing marathon

The progressive health care advocacy group Protect Our Care is releasing a highly critical review of Health and Human Services Secretary Robert F. Kennedy Jr.’s first 14 months in office ahead of a marathon series of hearings he will have in the House and Senate this month to defend President Trump’s budget request. In the report titled “Robert F. Kennedy Jr. vs. Public Health,” shown first to The Hill, …

Full Story

 

FDA to weigh lifting restrictions on some MAHA-favored peptides

The Food and Drug Administration (FDA) is taking the first steps toward potentially easing access to certain peptide injections that are currently restricted due to safety concerns. The agency on Wednesday said it is convening a meeting of an outside advisory panel in July to discuss whether to allow compounding pharmacies to manufacture peptides for ulcerative colitis, wound healing, obesity …

Full Story

 

 

 

CONTENT FROM OUR SPONSOR

Rising premiums are outpacing inflation

When insurer practices drive up costs, families feel it in their monthly premiums. Without reform, healthcare costs could continue rising faster than inflation—putting care further out of reach for millions of Americans. Learn more

 

 

In Other News

Branch out with a different read from The Hill:

Judge rules that HUD effort to change criteria for homeless funding is unlawful

A federal judge in Rhode Island ruled on Tues